
The Future Of Healthcare Is Collaborative—And AI Is The Catalyst
Collaboration and AI in Indian health care
A quiet revolution is underway in the heart of a radiology lab at Apollo Hospitals in Chennai, India. Artificial intelligence is scanning high-resolution images, flagging anomalies, reducing the time for diagnosis, and improving accuracy. But what makes this advancement so powerful isn't just the algorithm behind it. It's the collaboration between a hospital, a tech company, and a university that makes AI innovation sustainable, scalable, and relevant to India's complex healthcare landscape.
Across India, a new model of digital health transformation is emerging, one where partnerships are as crucial as platforms. For a country grappling with massive disparities in healthcare access and delivery, this shift couldn't be more timely. These are the observations and conclusions from my peer, Dr. Priyanka Shrivastava, who is a Professor of Marketing & Analytics at Hult International Business School and an Executive Fellow at The Digital Economist.
India's healthcare system faces deep challenges: a rapidly growing population, stark urban-rural divides, a chronic shortage of medical professionals, and overstretched public infrastructure. While the proliferation of health-tech startups has brought promise, much of the innovation remains confined to urban pockets or pilot projects.
AI detects disease, streamlines diagnosis, and personalizes treatment. Tools like AI-powered nutrition coaches (HealthifyMe's Ria) and automated diagnostic assistants (such as those used by Aindra or Columbia Asia Hospital) are transforming the delivery of healthcare.
Yet, these tools often encounter barriers due to a lack of interoperability, fragmented data systems, regulatory uncertainty, and resistance from overworked staff who fear that AI might be more of a disruption than an aid.
Technology alone cannot fix healthcare. But technology plus collaboration just might.
In a recent study, Dr. Shrivastava and her colleagues surveyed 300 healthcare professionals across 50 institutions and held in-depth interviews with doctors, technologists, and policymakers. The results were striking: institutions with strong cross-sector collaborations consistently showed higher and more sustained AI adoption.
Three core insights emerged:
Urban hospitals often have access to advanced technology and data, whereas rural clinics often lack even basic diagnostic capabilities. But when these entities partner via telemedicine links, shared platforms, or co-funding arrangements, AI can extend its reach. For example, Apollo's AI systems, when linked with satellite clinics, enable faster referrals and better triage in underserved regions.
Resistance to AI isn't irrational—it often stems from a lack of understanding. The study found that joint workshops, where doctors and engineers co-learned and co-created, built buy-in from healthcare workers. When staff are trained with the tools and understand how they were developed, they are far more likely to embrace them.
AI isn't plug-and-play. It requires regular updates, feedback loops, and cultural alignment. Institutions that formalized collaboration through MOUs, shared R&D labs, or co-published studies were more likely to sustain AI programs over the long term.
Apollo's AI-driven radiology initiative in Chennai is a textbook example. Faced with long diagnosis times and overburdened radiologists, the hospital sought a solution. Instead of simply buying an off-the-shelf AI tool, Apollo co-developed one with a university, providing algorithm expertise, and a startup delivering the technical infrastructure.
Doctors and developers worked side by side. The result? Diagnosis time dropped by 30%, and accuracy improved by 15%. Radiologists weren't replaced—they were enhanced, with AI acting as a second pair of eyes. Continuous training and feedback ensured the system evolved with practice.
This wasn't a one-off deployment. It was an ecosystem. And that made all the difference.
While Apollo represents a private success, the public sector isn't far behind. India's eSanjeevani platform, which added AI-supported teleconsultation features during the pandemic, saw a 40% increase in rural usage. This shows that with the right support and scale, AI can democratize access to care.
The National Digital Health Mission is another promising initiative. If executed well—with strong data privacy frameworks and open APIs—it can offer a common layer for innovation. Startups can plug into public records; government hospitals can access AI-enabled diagnostics; researchers can draw insights from anonymized data.
But for this to happen, policymakers must prioritize collaboration frameworks just as much as digital infrastructure.
As India enters a defining decade for health innovation, here are four actionable takeaways from the research:
Tax breaks, innovation grants, and pilot funding for joint ventures in AI health can catalyze adoption. Startups gain credibility and scale; public hospitals get access to frontier tech.
Set up AI literacy programs for frontline health workers. Encourage interdisciplinary training so doctors, nurses, and tech teams speak a common language.
A national framework on health data interoperability is overdue. Without this, AI solutions cannot scale beyond one institution. Build trust through consent-driven, encrypted data-sharing norms.
Mandate impact audits for all health AI deployments—measuring not just tech efficiency, but patient outcomes, staff satisfaction, and system-level equity.
The most inspiring part of this story? AI in Indian healthcare isn't being driven solely by top-down mandates or Silicon Valley imports. It's being shaped organically by Indian doctors, engineers, policy thinkers, and entrepreneurs who are joining forces.
This pluralistic model with many voices but one mission could well become a template for emerging economies around the world. In a landscape where access to a doctor can mean the difference between life and death, AI's potential is undeniable. But its success will depend on something far more human: our ability to collaborate. The most transformative technology for health care is not an algorithm. It is the alignment of purpose, people, vision, and AI through collaboration.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 hours ago
- Yahoo
As Layoffs Mount, One Question Is Getting Louder: What Happens To Skyscraper Offices In Cities Like Boston When People Are Replaced By AI?
As artificial intelligence keeps reshaping the workforce, more people are starting to wonder what will happen to all the towering office buildings in downtown areas. With companies pushing for efficiency and reducing headcounts, large office spaces are already sitting half-empty. According to the latest Moody's Analytics report, the average vacancy rate for office property in the U.S. is 20.4%, which is the highest vacancy rate on record. Don't Miss: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — 'Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. A new report from the Boston Policy Institute estimates that the city of Boston could lose $1.7 billion in tax revenue over the next five years because of empty offices and falling property values. 'Things are not getting better,' Evan Horowitz, executive director of Tufts University's Center for State Policy Analysis, which co-published the report, told WBUR-FM recently. 'Offices remain empty. Their valuations continue to fall. We think they'll fall further than we thought.' The report projects a growing budget shortfall in Boston, from $135 million this year to more than $550 million by 2029. The assessed value for office buildings has already dropped 9% this fiscal year, a dip similar to what was seen during the 2008 financial crisis. Some buildings have reportedly sold at discounts as steep as 70%. According to the report, Boston is especially vulnerable because more than a third of its budget comes from commercial property taxes. By comparison, other U.S. cities rely on that type of revenue for just 11% of their budgets. To make matters worse, Massachusetts law limits Boston's ability to raise money through other taxes. Trending: Invest where it hurts — and help millions heal:. While policymakers debate revenue forecasts, many people online are raising a more basic question: 'What happens to skyscraper offices in the city center when people are replaced by AI?' This exact question was posed on a recent Reddit thread in r/Layoffs, and users floated a range of possibilities. Some were skeptical about AI entirely replacing workers, calling it more of a smokescreen. 'AI is just a buzzword. Most of these jobs are being replaced by Indian and Philippines workers who work entirely remotely,' one person wrote. Others focused on real estate: 'Convert them to luxury apartments.' Another user pushed back, noting how expensive that process can be: 'This is always way more expensive than people think because the offices were not set up with electrical/plumbing/heat that is suitable for apartments.' Some suggested turning empty towers into data centers, housing, or even hotels. 'Hotel Torre Catalunya used to be an office building and they transformed it into a hotel here in Barcelona,' one Redditor said. But others were more cynical, claiming cities would 'rather demolish these office towers than convert them to affordable housing.' One comment captured the growing sense of frustration: 'We are quickly moving into cyberpunk/corporate fiefdoms territory.'The larger concern is that cities like Boston built their budgets around the assumption that office life was permanent. Now, with hybrid work becoming the norm and companies leaning on automation, that model is looking shaky. 'We can't rely on big office towers that attract commuting workers,' Horowitz told WBUR. 'It doesn't mean the city can't be vibrant. The city has lots of other amenities that people enjoy. It just has to find a new way to secure its future strength.' For now, city leaders, business owners and regular workers are all stuck asking the same question: What do we do with all this space? Read Next: Here's what Americans think you need to be considered wealthy. Deloitte's fastest-growing software company partners with Amazon, Walmart & Target – Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article As Layoffs Mount, One Question Is Getting Louder: What Happens To Skyscraper Offices In Cities Like Boston When People Are Replaced By AI? originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
Yahoo
12 hours ago
- Yahoo
Aayush Wellness Bridging Ancient Ayurvedic Wisdom with Modern Wellness offering Aayush Herbal Masala
NEW DELHI, India, June 12, 2025 (GLOBE NEWSWIRE) -- Aayush Wellness Limited, a trailblazer in India's preventive healthcare sector, seamlessly integrates the time-honored principles of Ayurveda with contemporary scientific advancements. Their product line exemplifies this fusion, offering holistic solutions tailored to modern lifestyles. Aayush Wellness Embracing Ayurveda: The Science of Life & Healthy Living. At the heart of Aayush Wellness's philosophy lies Ayurveda, the ancient Indian system of medicine that emphasizes balance and harmony within the body, mind, and spirit. Ayurveda advocates for a holistic approach to health, focusing on preventive care and the maintenance of well-being through natural means. Aayush Wellness harnesses this wisdom by formulating products that align with Ayurvedic principles, ensuring that each offering not only addresses specific health concerns but also contributes to overall vitality. By doing so, they provide consumers with tools to lead balanced, healthful lives rooted in time-tested traditions. Aayush Range of Product Highlights: Aayush Herbal Masala: Positioned as a natural alternative to traditional pan masala, this herbal blend is crafted to provide a refreshing experience without the adverse effects associated with tobacco-based products. It caters to individuals seeking healthier lifestyle choices. Aayush Herbal Masala Savings Pack: This value pack offers the same benefits as the standard Herbal Masala, making it an economical choice for regular consumers committed to wellness. Beauty Vitamin Gummies: These gummies are formulated to support radiant skin, span nails, and healthy hair. Enriched with essential vitamins and antioxidants, they aim to enhance natural beauty from within. Dreamy Sleep Gummies: Addressing the prevalent issue of sleep disturbances, these gummies combine melatonin, L-tryptophan, chamomile, tagar, and brahmi. This blend isdesigned to promote relaxation and improve sleep quality, offering a natural remedy for restful nights. Aayush Herbal Pan Masala: Similar in intent to the Herbal Masala, this product provides a tobacco-free alternative for those seeking to transition away from conventional pan masala, aligning with healthier consumption habits. Each product reflects Aayush Wellness's commitment to delivering natural, effective solutions that resonate with the needs of contemporary consumers. Aayush Wellness Limited [BSE:539528], India's preventive healthcare company, is taking a significant step toward accessible and proactive healthcare by launching its first healthcare centre in Virar (Mumbai), Maharashtra. Inspired by the E Sanjeevani National Telemedicine Service of the Ministry of Health and Family Welfare, Aayush Wellness has installed a health ATM that shall conduct a wide range of diagnostics tests, in 2-3 minutes, maintain digital health records, and also facilitate Telemedicine to address health deficiencies before they become critical. Aayush Wellness unveils its first Smart Health ATM in Virar, Mumbai, India, bringing fast diagnostics and telemedicine access to local communities. The Company plans to invest up to 3 Million $ in the first phase and shall review further investments based on business requirements. This expansion will increase the company's physical presence across geographies all over India, improve the offline distribution network for our products and provide complete preventive healthcare solutions under one roof. The company envisions a future where preventive healthcare becomes a cornerstone of everyday life, reducing dependency on reactive treatments. With this initiative, Aayush Wellness Limited continues to strengthen its presence in the $372 billion Indian healthcare market, offering solutions that cater to the evolving needs of consumers. Mr. Naveena Kumar, Managing Director of Aayush Wellness Limited said 'The Cloud Clinic model through this Health ATM is unique as it will deliver affordable yet high quality healthcare services to under privileged population of India. Our solution not only promotes early detection and prevention but also empowers individuals, especially those in rural and semi-urban areas, to take charge of their health in an accessible, cost-effective manner.' The health ATM shall be able to conduct a up to 59 test including blood test, sugar test, Urine test, Haemoglobin test, skin test, eye test, cancer risk test, Lipid Profile test, and other basic health checkups, at a very affordable price. Further, the health ATM shall also facilitate Telemedicine, maintain Digital Health Records, Cloud connectivity generates smart reports and integration with Ayushman Bharat Digital Mission to benefit majority of the Indian Population.' At Our Health and Medical Support centres, we shall also be able to promote and integrate with health programs and initiatives announced by the Government. Summary:Aayush Wellness stands at the intersection of tradition and innovation, delivering products that honor the rich heritage of Ayurveda while meeting the demands of modern health-conscious individuals. Through their diverse offerings, they empower consumers to make informed choices that support holistic well-being. Aayush Wellness Limited (Formerly known as Aayush Food and Herbs Limited) CIN: L01122DL1984PLC018307 Registered Office: 275, Ground Floor, West End Marg, Near Saket Metro Station Exit: 2, New Delhi-110030 Media Contact:Organization: Synergy Global Enterprise LLC Name: Gopi Divecha Contact Number: +6586940671 Address: 111 North Bridge Road #21²01, Singapore 179098 Website: Email: gopi@ Disclaimer: This press release is provided by the Aayush Wellness Limited. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. This content is for informational purposes only and should not be considered financial, investment, or trading advice. Investing involves significant risks, including the potential loss of capital. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility. Legal Disclaimer: This media platform provides the content of this article on an "as-is" basis, without any warranties or representations of any kind, express or implied. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned al recuperar los datos Inicia sesión para acceder a tu cartera de valores Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos

Yahoo
13 hours ago
- Yahoo
India's OneSource eyes weight-loss drug boost to order book
By Rishika Sadam (Reuters) -Indian contract drug manufacturer OneSource Specialty Pharma expects strong growth in its order book over the next three years, driven by the global boom in weight-loss drugs, its top executive said on Monday. Global drugmakers, including generic drug manufacturers in India, are racing to develop their versions of blockbuster injectable obesity drugs from Denmark's Novo Nordisk and U.S.-based Eli Lilly. The active chemical compound in Novo's injectable Wegovy drug, semaglutide, will go off patent in 2026 in a few markets, including India. OneSource, which added 15 orders related to obesity and diabetes drugs in fiscal year 2025, said there are more in the pipeline. The global obesity market is estimated to be valued at $150 billion by the early 2030s. The company develops and manufactures complex biological drugs, vials, injectables, and soft gelatin capsules for larger pharmaceutical firms. "Our growth over the next few years will be driven by commercial launches of GLP-1s (weight-loss and diabetes drugs) by our global customers in all the key markets opening post patent expiry in 2026," CEO Neeraj Sharma told Reuters in an interview. Backed by increasing demand from weight-loss drug manufacturers, OneSource's order book across all service verticals should expand in line with 30% compound annual growth rate through fiscal year 2028, according to the CEO. OneSource, which competes with larger players such as Piramal Pharma and Divi's in contract research, development and manufacturing, is investing about $100 million to expand its drug device facilities, the CEO said. The company, which was demerged from Strides Pharma Science and listed in January, is also looking at setting up a global footprint in manufacturing, both in Europe and the U.S. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data